Literature DB >> 12497574

Hypertrophy after free vascularized fibular transfer to the lower limb.

Tarek Abdalla El-Gammal1, Amr El-Sayed, Mohammed M Kotb.   

Abstract

This study included 25 patients with lower limb tumors who had reconstruction by vascularized fibula osteoseptocutaneous flap performed at least 24 months before the end of the study. Hypertrophy of the transplanted fibula was estimated on serial radiographs by a modification of the formula of De Boer and Wood (J Bone Joint Surg [Br] 71:374-378, 1989). A significant graft was observed in 90% of the patients at an average follow-up of 27 months (range, 30-200%). The time to graft union (start of partial weight-bearing) positively correlated with the time to significant graft hypertrophy (r = 0.9, P < 0.01). The final amount of graft hypertrophy was affected by the age of the patient (P < 0.01) and the length of follow-up (P < 0.05). Graft hypertrophy progressed at an average rate of 3.3% per month (range, 2.3-4.9%) until the end of the 30th month; thereafter, little or no increase in graft hypertrophy was observed. The rate of graft hypertrophy showed two significant peaks at 6-12 months (P < 0.001) and at 18-24 months (P < 0.05). Patients younger than age 20 years showed faster hypertrophy, with a peak at the 12th month. Hypertrophy progressed faster in patients who received chemotherapy until the 12th month, and then declined sharply compared to those who did not receive chemotherapy. Copyright 2002 Wiley-Liss, Inc. MICROSURGERY 22:367-370 2002

Entities:  

Mesh:

Year:  2002        PMID: 12497574     DOI: 10.1002/micr.10066

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  14 in total

Review 1.  [Free fibula transfer. Analysis of 76 consecutive microsurgical procedures and review of the literature].

Authors:  D Erdmann; G A Giessler; G E O Bergquist; W Bruno; H Young; C Heitmann; L S Levin
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

2.  [Bilateral fibula graft. Biological reconstruction following resection of malignant bone tumors].

Authors:  P-U Tunn; T K Moesta; H Delbrück
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

Review 3.  [Autologous fibula transplantation for reconstruction of bone defects].

Authors:  U Lenze; F Pohlig; C Knebel; F Lenze; N Harrasser; H Mühlhofer; A Toepfer; H Rechl; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2017-08       Impact factor: 1.087

Review 4.  Case reports: lengthening of a vascularized free fibular graft.

Authors:  Aurélien Courvoisier; Frédéric Sailhan; Pierre Mary; Jean-Paul Damsin
Journal:  Clin Orthop Relat Res       Date:  2008-12-10       Impact factor: 4.176

5.  Bony Hypertrophy in Vascularized Fibular Grafts.

Authors:  Lewis L Shi; Rohit Garg; Andrew Jawa; Qiaojie Wang; Yimin Chai; Bingfang Zeng; Jesse B Jupiter
Journal:  Hand (N Y)       Date:  2020-01-27

Review 6.  Salvage of a femoral nonunion after primary non-Hodgkin's lymphoma of bone: a case report and literature review.

Authors:  Xue Tao Xie; You Shui Gao; Chang Qing Zhang
Journal:  Med Sci Monit       Date:  2011-11

7.  Vascularized fibular graft in infected tibial bone loss.

Authors:  C Cheriyan Kovoor; R Jayakumar; Vv George; Vinod Padmanabhan; Aj Guild; Sabin Viswanath
Journal:  Indian J Orthop       Date:  2011-07       Impact factor: 1.251

8.  The versatility of the free osteocutaneous fibula flap in the reconstruction of extremities after sarcoma resection.

Authors:  Alexander D Bach; Jürgen Kopp; G Björn Stark; Raymund E Horch
Journal:  World J Surg Oncol       Date:  2004-07-01       Impact factor: 2.754

9.  Do stress fractures induce hypertrophy of the grafted fibula? A report of three cases received free vascularized fibular graft treatment for tibial defects.

Authors:  Yong Qi; Hong-Tao Sun; Yue-Guang Fan; Fei-Meng Li; Zhou-Sheng Lin
Journal:  Chin J Traumatol       Date:  2016-06-01

10.  Bilateral fibular graft: biological reconstruction after resection of primary malignant bone tumors of the lower limb.

Authors:  Maya Niethard; Carmen Tiedke; Dimosthenis Andreou; Frank Traub; Mario Kuhnert; Mathias Werner; Per-Ulf Tunn
Journal:  Sarcoma       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.